Donna Nichols, CAO/Controller at Recro Pharma, Inc. (REPH), bought 1,140 shares at $6.48 ($7K) on 2016-05-19, disclosed to the SEC on 2016-05-23.
Open-market purchase of $7k REPH by CAO/Controller. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.